TSHA logo

Taysha Gene Therapies, Inc. (TSHA) Operating Profit

Annual Operating Profit:

-$86.62M-$15.25M(-21.36%)
December 31, 2024

Summary

  • As of today, TSHA annual operating income is -$86.62 million, with the most recent change of -$15.25 million (-21.36%) on December 31, 2024.
  • During the last 3 years, TSHA annual operating profit has risen by +$86.65 million (+50.01%).
  • TSHA annual operating profit is now -7668.70% below its all-time high of -$1.11 million, reached on December 31, 2019.

Performance

TSHA Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTSHAincome statement metrics

Quarterly Operating Profit:

-$26.75M-$5.33M(-24.89%)
June 30, 2025

Summary

  • As of today, TSHA quarterly operating income is -$26.75 million, with the most recent change of -$5.33 million (-24.89%) on June 30, 2025.
  • Over the past year, TSHA quarterly operating profit has dropped by -$5.45 million (-25.61%).
  • TSHA quarterly operating profit is now -2299.37% below its all-time high of -$1.11 million, reached on December 1, 2019.

Performance

TSHA Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTSHAincome statement metrics

TTM Operating Profit:

-$89.17M-$5.45M(-6.52%)
June 30, 2025

Summary

  • As of today, TSHA TTM operating income is -$89.17 million, with the most recent change of -$5.45 million (-6.52%) on June 30, 2025.
  • Over the past year, TSHA TTM operating profit has dropped by -$12.11 million (-15.71%).
  • TSHA TTM operating profit is now -7896.95% below its all-time high of -$1.11 million, reached on December 1, 2019.

Performance

TSHA TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTSHAincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

TSHA Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-21.4%-25.6%-15.7%
3Y3 Years+50.0%+19.8%+50.7%
5Y5 Years-7668.7%--310.1%

TSHA Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-21.4%+50.0%-71.1%at low-24.9%+42.7%
5Y5-Year-7668.7%+50.0%-77.9%+47.2%-310.1%+52.6%
All-TimeAll-Time-7668.7%+50.0%-2299.4%+47.2%-7896.9%+52.6%

TSHA Operating Profit History

DateAnnualQuarterlyTTM
Jun 2025
-
-$26.75M(-24.9%)
-$89.17M(-6.5%)
Mar 2025
-
-$21.42M(-7.5%)
-$83.71M(+3.4%)
Dec 2024
-$86.62M(-21.4%)
-$19.93M(+5.4%)
-$86.62M(-5.0%)
Sep 2024
-
-$21.06M(+1.1%)
-$82.49M(-7.0%)
Jun 2024
-
-$21.30M(+12.5%)
-$77.06M(+2.6%)
Mar 2024
-
-$24.33M(-54.0%)
-$79.14M(-10.9%)
Dec 2023
-$71.37M(+43.4%)
-$15.80M(-1.0%)
-$71.37M(+3.9%)
Sep 2023
-
-$15.63M(+33.1%)
-$74.28M(+11.7%)
Jun 2023
-
-$23.38M(-41.2%)
-$84.10M(+10.6%)
Mar 2023
-
-$16.56M(+11.4%)
-$94.09M(+24.5%)
Dec 2022
-$126.03M
-$18.70M(+26.5%)
-$124.58M(+19.9%)
Sep 2022
-
-$25.46M(+23.7%)
-$155.60M(+13.9%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$33.37M(+29.1%)
-$180.83M(+3.9%)
Mar 2022
-
-$47.05M(+5.4%)
-$188.23M(-8.6%)
Dec 2021
-$173.27M(-302.9%)
-$49.72M(+1.9%)
-$173.27M(-22.1%)
Sep 2021
-
-$50.68M(-24.3%)
-$141.91M(-33.5%)
Jun 2021
-
-$40.77M(-27.1%)
-$106.27M(-62.2%)
Mar 2021
-
-$32.09M(-74.7%)
-$65.50M(-68.0%)
Dec 2020
-$43.00M(-3756.7%)
-
-
Dec 2020
-
-$18.37M(-22.1%)
-$38.99M(-79.4%)
Sep 2020
-
-$15.04M(-169.4%)
-$21.74M(-224.5%)
Mar 2020
-
-$5.58M(-400.8%)
-$6.70M(-500.8%)
Dec 2019
-$1.11M
-
-
Dec 2019
-
-$1.11M
-$1.11M

FAQ

  • What is Taysha Gene Therapies, Inc. annual operating income?
  • What is the all-time high annual operating profit for Taysha Gene Therapies, Inc.?
  • What is Taysha Gene Therapies, Inc. annual operating profit year-on-year change?
  • What is Taysha Gene Therapies, Inc. quarterly operating income?
  • What is the all-time high quarterly operating profit for Taysha Gene Therapies, Inc.?
  • What is Taysha Gene Therapies, Inc. quarterly operating profit year-on-year change?
  • What is Taysha Gene Therapies, Inc. TTM operating income?
  • What is the all-time high TTM operating profit for Taysha Gene Therapies, Inc.?
  • What is Taysha Gene Therapies, Inc. TTM operating profit year-on-year change?

What is Taysha Gene Therapies, Inc. annual operating income?

The current annual operating profit of TSHA is -$86.62M

What is the all-time high annual operating profit for Taysha Gene Therapies, Inc.?

Taysha Gene Therapies, Inc. all-time high annual operating income is -$1.11M

What is Taysha Gene Therapies, Inc. annual operating profit year-on-year change?

Over the past year, TSHA annual operating income has changed by -$15.25M (-21.36%)

What is Taysha Gene Therapies, Inc. quarterly operating income?

The current quarterly operating profit of TSHA is -$26.75M

What is the all-time high quarterly operating profit for Taysha Gene Therapies, Inc.?

Taysha Gene Therapies, Inc. all-time high quarterly operating income is -$1.11M

What is Taysha Gene Therapies, Inc. quarterly operating profit year-on-year change?

Over the past year, TSHA quarterly operating income has changed by -$5.45M (-25.61%)

What is Taysha Gene Therapies, Inc. TTM operating income?

The current TTM operating profit of TSHA is -$89.17M

What is the all-time high TTM operating profit for Taysha Gene Therapies, Inc.?

Taysha Gene Therapies, Inc. all-time high TTM operating income is -$1.11M

What is Taysha Gene Therapies, Inc. TTM operating profit year-on-year change?

Over the past year, TSHA TTM operating income has changed by -$12.11M (-15.71%)
On this page